Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2025-12-25 @ 3:23 AM
NCT ID:
NCT07125105
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of myasthenia gravis of any form established by a referring neurologist.
* Patients followed at Lille University Hospital and its partners (Neuromuscular Diseases Reference Center, hospitals of the Côte d'Opale, home care services), or at Amiens University Hospital.
* No major contraindications to participating in adapted physical activity and/or art therapy, as evaluated by the medical team.
* Availability to attend all 10 sessions of the APA-only program and the combined APA + AT program, according to the cross-over design.
* Signed informed consent after being informed about the objectives and requirements of the project.
Exclusion Criteria:
* Severe comorbidities limiting participation in adapted physical activity or art therapy.
* Advanced cognitive decline or severe neuropsychiatric disorders preventing understanding and participation.
* Unstable medical treatment with recent changes that may affect fatigability or physical capacity / poorly controlled myasthenia gravis.
* Physical inability to participate in adapted physical activity or art therapy, even with adaptations.
* Unavailability to complete the entire protocol (e.g., relocation, prolonged absence).
* Refusal or inability to provide informed consent (e.g., patient under guardianship without legal authorization).
* Difficulty accessing the intervention locations without possible alternatives such as remote or home-based sessions.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07125105
Study Brief:
Protocol Section:
NCT07125105